163 related articles for article (PubMed ID: 2008903)
1. Cloning and expression of the oxalyl-CoA decarboxylase gene from the bacterium, Oxalobacter formigenes: prospects for gene therapy to control Ca-oxalate kidney stone formation.
Lung HY; Cornelius JG; Peck AB
Am J Kidney Dis; 1991 Apr; 17(4):381-5. PubMed ID: 2008903
[TBL] [Abstract][Full Text] [Related]
2. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
Peck AB; Canales BK; Nguyen CQ
Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
[TBL] [Abstract][Full Text] [Related]
3. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
Troxel SA; Sidhu H; Kaul P; Low RK
J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
[TBL] [Abstract][Full Text] [Related]
5. Designing a diagnostic kit for Oxalyl CoA Decarboxylase enzyme by ELISA method.
Abarghooi-Kahaki F; Basiri A; Bandehpour M; Kazemi B
Immunol Lett; 2019 Jan; 205():78-83. PubMed ID: 30447308
[TBL] [Abstract][Full Text] [Related]
6. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
Jafari GA; Fotouhi Ardakani R; Akhavan Sepahi M; Nowroozi J; Soltanpour MS
Iran J Kidney Dis; 2021 May; 15(3):190-198. PubMed ID: 33994378
[TBL] [Abstract][Full Text] [Related]
7. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, DNA sequence, and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes.
Lung HY; Baetz AL; Peck AB
J Bacteriol; 1994 Apr; 176(8):2468-72. PubMed ID: 8157618
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of the oxc and frc genes from Oxalobacter formigenes in human embryo kidney 293 cells: implications for gene therapy of hyperoxaluria.
Ye ZQ; Kong DB; Chen ZQ; Yao LF; Guo H; Yu X; Liu GL; Yang WM
Int J Mol Med; 2007 Oct; 20(4):521-6. PubMed ID: 17786282
[TBL] [Abstract][Full Text] [Related]
10. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
Gnanandarajah JS; Abrahante JE; Lulich JP; Murtaugh MP
Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
[TBL] [Abstract][Full Text] [Related]
11. Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis.
Federici F; Vitali B; Gotti R; Pasca MR; Gobbi S; Peck AB; Brigidi P
Appl Environ Microbiol; 2004 Sep; 70(9):5066-73. PubMed ID: 15345383
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on an old grouping: The genomic and phenotypic variability of
Chmiel JA; Carr C; Stuivenberg GA; Venema R; Chanyi RM; Al KF; Giguere D; Say H; Akouris PP; DomÃnguez Romero SA; Kwong A; Tai V; Koval SF; Razvi H; Bjazevic J; Burton JP
Front Microbiol; 2022; 13():1011102. PubMed ID: 36620050
[No Abstract] [Full Text] [Related]
13. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
Abratt VR; Reid SJ
Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
[TBL] [Abstract][Full Text] [Related]
14. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.
Kaufman DW; Kelly JP; Curhan GC; Anderson TE; Dretler SP; Preminger GM; Cave DR
J Am Soc Nephrol; 2008 Jun; 19(6):1197-203. PubMed ID: 18322162
[TBL] [Abstract][Full Text] [Related]
15. Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation.
Watterson JD; Cadieux PA; Beiko DT; Cook AJ; Burton JP; Harbottle RR; Lee C; Rowe E; Sidhu H; Reid G; Denstedt JD
J Endourol; 2003 Jun; 17(5):269-74. PubMed ID: 12885351
[TBL] [Abstract][Full Text] [Related]
16. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis.
Mittal RD; Kumar R
J Endourol; 2004 Jun; 18(5):418-24. PubMed ID: 15253809
[TBL] [Abstract][Full Text] [Related]
17. Oxalobacter formigenes and its role in oxalate metabolism in the human gut.
Stewart CS; Duncan SH; Cave DR
FEMS Microbiol Lett; 2004 Jan; 230(1):1-7. PubMed ID: 14734158
[TBL] [Abstract][Full Text] [Related]
18. Oxalate-degrading Providencia rettgeri isolated from human stools.
Hokama S; Toma C; Iwanaga M; Morozumi M; Sugaya K; Ogawa Y
Int J Urol; 2005 Jun; 12(6):533-8. PubMed ID: 15985073
[TBL] [Abstract][Full Text] [Related]
19. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
Mittal RD; Kumar R; Mittal B; Prasad R; Bhandari M
Med Princ Pract; 2003; 12(4):208-13. PubMed ID: 12966191
[TBL] [Abstract][Full Text] [Related]
20. The role of the microbiome in kidney stone formation.
Mehta M; Goldfarb DS; Nazzal L
Int J Surg; 2016 Dec; 36(Pt D):607-612. PubMed ID: 27847292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
